Drugs / human autologous synovial stem cells
last change Dec 2025 re-read 3 minutes ago

human autologous synovial stem cells

Cell therapy

Investigated by
FUJIFILM Toyama Chemical Co., Ltd.

Trials 1

2023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT05777967 Jan 2023 → Dec 2024 — FUJIFILM Toyama Chemical Co., Ltd. Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as human autologous synovial stem cells ClinicalTrials.gov intervention name — accepted as the source's own label NCT05777967 ↗
Modality Cell therapy “Biological: human autologous synovial stem cells” NCT05777967 ↗